The Cancer of the Pancreas Screening-5 CAPS5)Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02000089

Title field or adapter rule

{'original_value': 'The Cancer of the Pancreas Screening-5 CAPS5)Study', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:22.665380+00:00

Published At

2026-10-22T00:00:00+00:00

Record Updated At

2026-10-22

Source Retrieved At

2026-10-31T22:19:02.163121+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Pancreas Cancer", "Peutz-Jeghers Syndrome (PJS)", "Gene Mutation", "Germline Mutation Carrier", "Lynch Syndrome"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-22", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT02000089"

protocolSection.identificationModule.officialTitle

"The Cancer of the Pancreas Screening-5 CAPS5)Study"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Pancreas Cancer (protocolSection.conditionsModule.conditions)
• Peutz-Jeghers Syndrome (PJS) (protocolSection.conditionsModule.conditions)
• Gene Mutation (protocolSection.conditionsModule.conditions)
• Germline Mutation Carrier (protocolSection.conditionsModule.conditions)
• Lynch Syndrome (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Chronic Pancreatitis', 'Familial pancreas cancer relatives', 'Group 1 germline mutation carrier', 'Group 2 germline mutation carrier', 'Hereditary pancreatitis', 'Negative control', 'Pancreas cancer', 'Pancreas cyst, IPMN evaluation', 'Peutz-Jeghers Syndrome'], 'description': 'inject Secretin to stimulate pancreatic digestive fluid, which is collected in duodenum near ampulla via endoscope suction port. This fluid will be assessed for biomarkers.', 'name': 'Secretin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Familial pancreas cancer relatives', 'Group 1 germline mutation carrier', 'Group 2 germline mutation carrier', 'Hereditary pancreatitis', 'Peutz-Jeghers Syndrome'], 'description': 'MRI abdomen with contrast (MRCP) will be clinically indicated for abnormal novel CA-19-9 lab results.', 'name': 'MRI', 'type': 'DIAGNOSTIC_TEST'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Familial pancreas cancer relatives', 'Group 1 germline mutation carrier', 'Group 2 germline mutation carrier', 'Hereditary pancreatitis', 'Peutz-Jeghers Syndrome'], 'description': 'A tumor marker gene test that will be used to stratify individuals into one of several circulating tumor marker reference ranges for CA19-9. The variants in the genes FUT3 and FUT2 affect the levels of CA19-9.', 'name': 'Tumor marker gene test with CA19-9', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Secretin (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.